Limitations of molecular testing in combination with computerized tomographic for lung cancer screening
- PMID: 35803922
- PMCID: PMC9270395
- DOI: 10.1038/s41467-022-31419-9
Limitations of molecular testing in combination with computerized tomographic for lung cancer screening
Conflict of interest statement
The author declares the following competing financial interests: He has served as an investigator with IELCAP since 2001, data management grant of $35,000 in 2001 and reimbursement for travel and accommodations to attend semi-annual research meetings 2001–2017, Paid expert witness testimony in three medical monitoring lawsuits against Philip Morris Corp 2012–2018.
Comment in
-
Reply to: Limitations of molecular testing in combination with computerized tomographic for lung cancer screening.Nat Commun. 2022 Jul 8;13(1):3892. doi: 10.1038/s41467-022-31420-2. Nat Commun. 2022. PMID: 35803904 Free PMC article. No abstract available.
Comment on
-
Detection and characterization of lung cancer using cell-free DNA fragmentomes.Nat Commun. 2021 Aug 20;12(1):5060. doi: 10.1038/s41467-021-24994-w. Nat Commun. 2021. PMID: 34417454 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical